Important Issues in the Drug Treatment of Schizophrenia
Schizophrenia BulletinPublished 1 January 1980
John M. Davis, C. B. Schaffer, G. A. Killian, Carl O. Kinard, Chetwyn C. H. Chan
Citations284
SJR quartileQ1
SJR score2.14
SNIP1.67
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The large body of research demonstrating the effectiveness of antipsychotic drugs in the treatment of acute schizophrenia is selectively reviewed and recommendations are made concerning areas of psychopharmacologic research that require further development.
Abstract
The large body of research demonstrating the effectiveness of antipsychotic drugs in the treatment of acute schizophrenia is selectively reviewed. Research evidence relevant to the following issues is assessed; indications for selective treatment; characteristics of drug responders and nonresponders; indications for high dosage phenothiazine treatment; indications for maintenance therapy; benefits and risks of antipsychotic drugs. Recommendations are made concerning areas of psychopharmacologic research that require further development.
Keywords
MedicineNeuroscience
McGraw-Hill Book CompanyStatistical principles in experimental design.
26,927 Citations1962B. J. WINER
Wiley series in probability and statisticsStatistical Methods for Rates and Proportions
18,048 Citations2003Joseph L. Fleiss, Bruce Levin +1 more
Archives of General PsychiatryDrug and Sociotherapy in the Aftercare of Schizophrenic Patients
573 Citations1974Gerard E. Hogarty
Archives of General PsychiatryDrug and Family Therapy in the Aftercare of Acute Schizophrenics
522 Citations1978Michael J. Goldstein
Relapses during the six-week period and at six-month follow-up were least in patients who received both high-dose and family therapy (0%) and greatest at six months only for therapy patients originally receiving the high drug dose.
American Journal of PsychiatryOverview: maintenance therapy in psychiatry: I. Schizophrenia
410 Citations1975
This overview of the literature on prophylactic treatment of schizophrenia with maintenance antipsychotic drugs and affective disorders with lithium and tricyclics finds these drugs provide the potential for truly preventive psychiatry.
BMJTrial of Maintenance Therapy in Schizophrenia
338 Citations1971Julian Leff, J. K. Wing
Maintenance therapy seems of little value in patients with a good prognosis and in the severely ill, but it is of value in the indeterminate group between these two extremes.
BMJOutpatient Maintenance of Chronic Schizophrenic Patients with Long-acting Fluphenazine: Double-blind Placebo
261 Citations1973S.R. Hirsch, R. Gaind +3 more
Results confirm the usefulness of long-acting fluphenazine in maintenance therapy of chronic schizophrenic outpatients already established on the drug and highlight the need for adequate community services to deal with the residual chronic disabilities characteristic of these patients.
Archives of General PsychiatryDrug and Sociotherapy in the Aftercare of Schizophrenic Patients
242 Citations1974Gerard E. Hogarty
Among patients in the community, those treated with combined drug and sociotherapy adjust better than those taking the drug alone; to a greater extent, those receiving placebo alone adjustbetter than those receiving Placebo and Sociotherapy.
American Journal of PsychiatryTardive Dyskinesia in Patients Treated with Major Neuroleptics: A Review of the Literature
235 Citations1968George E. Crane
Although manifestations of tardive dyskinesia occur in a number of diseases of the central nervous system, there is considerable evidence that the largescale use of phenothiazines or similar drugs in recent years is responsible for the great number of patients in mental hospitals exhibiting myoclonia and choreo-athetoid symptoms.
Archives of General PsychiatryPhenothiazine Effects on Psychological and Psychophysiological Dysfunction in Chronic Schizophrenics
235 Citations1977Herbert Spohn
Drug treatment tended to improve ability to sustain set, to increase efficiency of selective attention, and to increase rate of information processing in chronic schizophrenics, and clinical improvement was correlated with reduction in attentional dysfunction.
Archives of General PsychiatrySchizophrenia—A Follow-up Study of Results of Treatment
174 Citations1976Philip R. A. May
Patients treated initially with drugs or ECT showed a trend toward spending less time in hospital after their release, and those who had been treated with milieu therapy had a longer stay dated from the time of admission.
Archives of General PsychiatryTemporal Effects of Drug and Placebo in Delaying Relapse in Schizophrenic Outpatients
159 Citations1977Gerard E. Hogarty
Analysis of the after care experience of 374 schizophrenic patients treated with drug or placebo reveals that while the risk of relapse does decline substantially, it remains twice as high for placebo- treated patients than drug-treated patients even after two years of treatment.
Archives of General PsychiatryHigh Dose Chlorpromazine Therapy in Chronic Schizophrenia
147 Citations1968Robert F. Prien
A large number of studies have been published on the use of chlorpromazine with chronic schizophrenic patients, and this study is likely to be the first of its kind to compare and contrast the effects of different doses of the drug on the same patient.
The British Journal of PsychiatryChanges in Schizophrenic Psychopathology and Ward Behaviour as a Function of Phenothiazine Treatment
147 Citations1965Solomon C. Goldberg, Gerald L. Klerman +1 more
Clinical experience increasingly asserts that the phenothiazines influence many manifestations of schizophrenic patients other than anxiety and excitement, including symptoms such as incoherent thought and apathy.
The British Journal of PsychiatryRelapse in Chronic Schizophrenics following Abrupt Withdrawal of Tranquilizing Medication
111 Citations1969Robert F. Prien, Jonathan Cole +1 more
The results from drug discontinuation studies are complex and contradictory, and some investigators report extremely high relapse rates while others report little deterioration even when drugs are withdrawn for long periods of time.
Archives of General PsychiatryPhenothiazines in Prevention of Psychiatric Hospitalization
94 Citations1967David M. Engelhardt
It is revealed that although chlorpromazine was highly effective early in treatment, its effectiveness diminished progressively over time, suggesting delay rather than prevention of hospitalization, and the existence of a finite subgroup of "hospitalization prone" patients in any given group of ambulatory schizophrenic patients.
The British Journal of PsychiatryPersistence of Extra-pyramidal Disorders and Psychiatric Relapse after Withdrawal of Long-Term Phenothiazine Therapy
91 Citations1972H. I. Hershon, Peter F. Kennedy +1 more
Phenothiazines are one group of drugs whose efficacies and dangers have been discussed in this way.
Archives of General PsychiatryVery High Dosage vs Standard Dosage Fluphenazine in Schizophrenia
84 Citations1975Frederic M. Quitkin
Analysis of Inpatient Multidimensional Psychiatric Scale scores indicate that some patients taking very high doses had akinesia, and extrapyramidal side-effect that in part accounted for their inferior response.
American Journal of PsychiatryTERMINATION OF CHLORPROMAZINE WITH SCHIZOPHRENIC PATIENTS
73 Citations1958Wilson Good, MAC STERLING +1 more
The primary purpose of this study was to determine the effect upon behavior of withdrawing chlorpromazine treatment after it had been established as the preferred treatment routine.
Archives of General PsychiatrySchizophrenia—A Follow-up Study of Results of Treatment
70 Citations1976Philip R. A. May
The study compares the follow-up outcome of five different treatment methods given to first-admission male and female schizophrenic patients in the hospital and concludes that both pose massive problems in execution, analysis, presentation, and interpretation.
American Journal of PsychiatryHigh Dose Trifluoperazine Therapy in Chronic Schizophrenia
63 Citations1969Robert F. Prien, Jerome Levine +1 more
It was shown that treatment response was related to length of hospitalization; short-term patients benefited most and most placebo patients who had been receiving low doses of phenothiazines before the study did not suffer deleterious effects while they were off medication.
Archives of General PsychiatryPremorbid Asocial Adjustment and Response to Phenothiazine Treatment Among Schizophrenic Inpatients
62 Citations1973Donald F. Klein
Results support the hypothesis that response to phenothiazine treatment differs between asocial and nonasocial patients, and chlorpromazine had consistently positive effects in reducing psychopathology among non asocial patients.
The British Journal of PsychiatryWithdrawal of Perphenazine in Chronic Schizophrenia
58 Citations1963Collin B. Whittaker, R. M. Hoy
Although phenothiazine drugs have been employed in the treatment of schizophrenia for approximately ten years, it is still uncertain of the best method of using these agents.
The British Journal of PsychiatryA Controlled Trial of Phenothiazine Withdrawal in Chronic Schizophrenic Patients
58 Citations1976Pamela Andrews, John Hall +1 more
Phenothiazine drugs were withdrawn from 17 chronic schizophrenic in-patients, with a control group of 14 patients remaining on active medication, and of the placebo group 35 per cent relapsed, relapse being related to the level of previous active medication.
Archives of General PsychiatryPrediction of Response to Phenothiazines in Schizophrenia
43 Citations1972Solomon C. Goldberg
An attempt to replicate findings of two earlier studies suggesting schizophrenics could be assigned, according to their pattern of presenting symptomatology, to that phenothiazine on which they are likely to improve most is reported.
American Journal of PsychiatryA Study of the Withdrawal of Chlorpromazine or Trifluoperazine in Chronic Schizophrenia
41 Citations1968MJ Morton
Because the importance of tranquilizing drugs has been difficult to assess precisely, the author undertook a study on the effect of the withdrawal of chlorpromazine and trifluoperazine on hospitalized male schizophrenics in England.
Canadian Psychiatric Association JournalAbrupt withdrawal of Chlorpromazine and Thioridazine from Schizophrenic In-Patients
37 Citations1966W. T. Melnyk, A. G. Worthington +1 more
Symptoms which characterized the patient's illness prior to phenothiazine treatment were observed in 50% of the Placebo Group by the end of the six weeks' withdrawal period and none of the Drug Group showed relapse symptoms.
PsychopharmacologyChlorpromazine in chronic schizophrenia: Behavioral dose-response relationships
34 Citations1970Mervin L. Clark, H. Rudy Ramsey +4 more
Little difference in clinical response was demonstrable between the 300 and 600 mg doses of CPZ except in the frequency of side effects and possible speed of onset or therapeutic effects, both being greater in the 600 mg group.
Archives of General PsychiatryFluphenazine Decanoate, Oral Fluphenazine, and Placebo in Treatment of Remitted Schizophrenics
33 Citations1977Arthur Rifkin
Rating scale data substantiating two findings are presented: (1) patients terminated on clinical grounds because of a schizophrenic relapse showed rating scale changes consistent with that diagnosis; and (2) the patients removed due to severe akinesia showed a worsening on items selected a priori to measure akinesIA, and when compared to survivors on the same items, showed significant differences--thus confirming clinical judgments.
Archives of General PsychiatryAbstracting Ability of Schizophrenics Before and During Phenothiazine Therapy
28 Citations1966Algimantas M. Shimkunas
Research with quantitative procedures disclosed a high positive correlation between IQ and ability to abstract proverbs for normals and schizophrenics, in contrast with Benjamin's earlier finding that literal answers are "much more common in intelligent schizophrenics than in mildly defective nonschizophrenics".
Archives of General PsychiatryPhenothiazine Effects in Good Premorbid Schizophrenics Divided Into Paranoid-Nonparanoid Status
26 Citations1973Lewis L. Judd
The findings of this study and others emphasize the importance of using the paranoid-nonparanoid and good-poor premorbid groupings when doing clinical and experimental research on schizophrenics.
PubMedHigh vs standard dosage fluphenazine HCL in acute schizophrenia.
26 Citations1978Donlon Pt, Arnold Meadow +2 more
The authors conclude that the rapid neuroleptization method is not superior to the fixed standard dosage method in treating acute schizophrenia.
Canadian Psychiatric Association JournalWithdrawal of Long-Term Phenothiazines from Chronically Hospitalized Psychiatric Patients
24 Citations1964G. Marjerrison, D.G. Irvine +4 more
An investigation of trifluoperazine and chlorprothixene within the same double-blind design indicated that both were significantly more effective than placebo in maintaining the behavioural level typical of the prior long-term medication with phenothiazines.
PubMedPimozide in chronic schizophrenic outpatients.
24 Citations1975Mervin L. Clark, Wolfgang Huber +3 more
Thiordazine in single daily doses not exceeding 375 mg./day for 6 months was shown to be effective maintenance treatment compared with PL, thereby establishing the sensitivity of the experiment.
PubMedChlorpromazine in chronic schizophrenia. The effect of age and hospitalization on behavioral dose-response relationships.
20 Citations1972Mervin L. Clark, H. Rudy Ramsey +4 more
The Journal of Nervous and Mental DiseaseCLINICAL JUDGMENT IN THE ASSESSMENT OF PSYCHOPHARMACOLOGICAL EFFECTS
17 Citations1966Alfonso Paredes, John Baumgold +2 more
The British Journal of PsychiatryMethodological Problems in Psychotherapy Research: Observations on the Karon-VandenBos Study of Psychotherapy and Drugs in Schizophrenia
11 Citations1970Philip R. A. May, A. Hussain Tuma
It is indicated that, even when given by experienced therapists, psychotherapy for hospitalized schizophrenic patients is, in general, relatively ineffective, while drug therapy enhances results regardless of the therapist's experience.
PubMedHigh and low dose thiothixene treatment in chronic schizophrenia.
9 Citations1974G. Gárdos, Orzack Mh +2 more
Methodological problems of sample size, lost performance and EEG data, fixed dose level, and refractory patients probably account for the paucity of statistically significant dose differences.